Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Repligen Corporation - Common Stock
(NQ:
RGEN
)
155.38
-3.88 (-2.44%)
Official Closing Price
Updated: 4:15 PM EST, Mar 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
466,369
Open
159.44
Bid (Size)
148.59 (1)
Ask (Size)
162.88 (1)
Prev. Close
159.26
Today's Range
153.81 - 160.99
52wk Range
113.50 - 203.13
Shares Outstanding
55,679,964
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Analyst Verdict: Repligen In The Eyes Of 4 Experts
February 21, 2025
Via
Benzinga
Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook
February 20, 2025
Repligen reported Q4 EPS of $0.44, beating estimates, with revenue of $167.55 million. The company projects 2025 sales of up to $710 million as the market recovers.
Via
Benzinga
Performance
YTD
+8.62%
+8.62%
1 Month
-6.52%
-6.52%
3 Month
+3.27%
+3.27%
6 Month
+9.58%
+9.58%
1 Year
-20.61%
-20.61%
More News
Read More
Repligen's Q4 Slightly Tops Expectations
February 20, 2025
Via
The Motley Fool
Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates
February 20, 2025
Via
StockStory
Exposures
COVID-19
Earnings Scheduled For February 20, 2025
February 20, 2025
Via
Benzinga
Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow
February 19, 2025
Via
StockStory
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Evaluating Repligen: Insights From 6 Financial Analysts
September 26, 2024
Via
Benzinga
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
July 31, 2024
Via
Benzinga
3 Healthcare Stocks Skating on Thin Ice
February 12, 2025
Via
StockStory
Topics
Stocks
Exposures
COVID-19
US Equities
Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term Growth
November 12, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
10 Health Care Stocks Whale Activity In Today's Session
November 12, 2024
Via
Benzinga
Wall Street Ticks Up As Consumer Sentiment Improves; Gold Hits Record Highs, Boosting Mining Stocks: What's Driving Markets Friday?
August 16, 2024
Via
Benzinga
Repligen Corp. (NASDAQ: RGEN) Making Surprising Moves in Tuesday Session
April 23, 2024
Via
Investor Brand Network
Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio?
August 04, 2024
Via
Benzinga
Here's Why Shares in This Hot Healthcare Stock Surged This Week
August 02, 2024
Via
The Motley Fool
Repligen Lowers Guidance On China Weakness, Analyst Expects
July 30, 2024
Via
Benzinga
PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
July 30, 2024
Via
Benzinga
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 30, 2024
Via
Benzinga
This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
June 26, 2024
Via
Benzinga
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
June 26, 2024
Via
Benzinga
Top 3 Health Care Stocks That Could Blast Off In June
June 21, 2024
Via
Benzinga
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 13, 2024
Via
Benzinga
RGEN Stock Earnings: Repligen Misses EPS, Beats Revenue for Q1 2024
May 01, 2024
Via
InvestorPlace
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
April 23, 2024
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.